Biotechnology company Rezera (RZRA.US) delays its $200 million IPO in the US.
智通财经2026/11/16 06:56Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
According to Jinse Finance APP, Rezera (RZRA.US), a biotech company developing oral NLRP3 inflammation inhibitors with its pipeline already advanced to Phase III clinical trials, announced last Thursday that it will postpone its listing. The company had previously filed for an IPO, planning to issue 16.7 million shares within a price range of $11–$13, aiming to raise $200 million. Pharmaceutical company GSK (GSK.US), as a new investor and its affiliates, has committed to subscribing up to $25 million, accounting for 13% of this offering.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Crypto prices
MoreBitcoin
BTC
$64,616.78
+1.04%
Ethereum
ETH
$1,810.35
+1.61%
Tether USDt
USDT
$0.9990
-0.04%
BNB
BNB
$592.44
+1.08%
USDC
USDC
$0.9998
+0.00%
XRP
XRP
$0.9554
+0.60%
Solana
SOL
$71.02
+1.50%
TRON
TRX
$0.3027
-1.18%
Hyperliquid
HYPE
$66.69
+2.76%
Zcash
ZEC
$893.57
-0.08%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now
